Advancing Bispecific and Combination Therapy to the Clinic focuses on novel concepts and their developments. Presentations will include synergistic combinations together with their rationale and provide data showing improved performance, including potency, targeting, stability, half-life and reduced toxicity. Preclinical studies leading up to proof-of-concept and IND enabling studies will be included as well as developments up to phases 2 and 3 for the more advanced products.  

Coverage will include, but is not limited to:

 

  • Bispecifics for checkpoint inhibitors together and in combination with agonists
  • T-cell engagement, particularly bispecifics that demonstrate superiority in terms of low levels of cytokine release, improved potency and specificity, and longer half-life to avoid continuous infusion
  • Bispecific engagement of NK cells
  • Bispecific cytokines demonstrating improved properties and a balance between safety and efficacy
  • Effective non-bispecific combination therapies
  • Novel bispecific formats including interesting combinations with mechanistic data
  • Design to proof-of-concept demonstrating benefits of bispecifics over antibodies in combination
  • Preclinical and clinical results including predictive studies, proof-of-concept and data from advanced products in
    Phases 2 and 3
  • IND enabling studies: immunogenicity profiling, formulation, production, and clinical strategy

If you would like to submit a proposal to give a presentation at this meeting, please CLICK HERE.

 

The deadline for priority consideration is 26 April 2019.

 

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

Nicole Lyscom, PhD

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+44) 7791 866489
Email: nlyscom@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K
Jason Gerardi
Senior Manager, Business Development

Cambridge Healthtech Institute
Phone: (+1) 781.972.5452
Email: jgerardi@healthtech.com

 

Companies L-Z
Ashley Parsons
Manager, Business Development

Cambridge Healthtech Institute
Phone: (+1) 781.972.1340
Email: ashleyparsons@healthtech.com